Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

  • staffstaff
  • AI
  • March 31, 2025
  • 0 Comments

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google’s parent, it said.     The funding will accelerate further development of Isomorphic’s AI drug […]

  • Related Posts

    Opera adds its Aria AI assistant to Opera Mini browser

    Norway-based browser company Opera said today that it is making its AI assistant Aria available to Opera Mini users on Android. This move will help users with low-end devices and data…

    Continue reading
    Grok gains a canvas-like tool for creating docs and apps

    Grok, the chatbot from Elon Musk’s AI company, xAI, has gained a canvas-like feature for editing and creating documents and basic apps. Called Grok Studio, the feature was announced on…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Opera adds its Aria AI assistant to Opera Mini browser

    • By staff
    • April 16, 2025
    • 0 views

    Grok gains a canvas-like tool for creating docs and apps

    • By staff
    • April 16, 2025
    • 2 views

    Nvidia H20 chip exports hit with license requirement by US government

    • By staff
    • April 15, 2025
    • 1 views

    Telli, a YC alum, raises pre-seed funding for its AI voice agents

    • By staff
    • April 15, 2025
    • 3 views